Skip to content
10-Q

Quarterly Report

XERIANT, INC. XERI

0001477932-24-000713

← back to feed
Filed
Feb 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Feb 12, 2024 445.04M sh
Capex Q2 2024 · Dec 31, 2023 $0
Capex Q2 2024 · Dec 31, 2022 $2.57K
Stockholders Equity Q2 2024 · Dec 31, 2023 −$7.85M
Stockholders Equity Q2 2024 · Sep 30, 2023 −$6.9M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$6.62M
Stockholders Equity restated Q2 2024 · Dec 31, 2022 −$5.9M
Stockholders Equity Q2 2024 · Sep 30, 2022 −$5.51M
Stockholders Equity restated Q2 2024 · Jun 30, 2022 −$2.96M
Current Liabilities Q2 2024 · Dec 31, 2023 $7.94M
Current Liabilities Q2 2024 · Jun 30, 2023 $6.75M
Total Liabilities Q2 2024 · Dec 31, 2023 $7.98M
Total Liabilities Q2 2024 · Jun 30, 2023 $6.79M
Current Assets Q2 2024 · Dec 31, 2023 $53.43K
Current Assets Q2 2024 · Jun 30, 2023 $66.15K
Total Assets Q2 2024 · Dec 31, 2023 $129.01K
Total Assets Q2 2024 · Jun 30, 2023 $167.12K
Net Income Q2 2024 · Sep 30, 2023 −$342.01K
Net Income Q2 2024 · Dec 31, 2022 −$1.29M
Net Income Q2 2024 · Dec 31, 2022 −$6.11M
Net Income Q2 2024 · Sep 30, 2022 −$4.82M
Operating Cash Flow Q2 2024 · Dec 31, 2022 −$943.79K
Rd Expense Q2 2024 · Dec 31, 2022 $0
Rd Expense Q2 2024 · Dec 31, 2022 $0
Operating Income Q2 2024 · Dec 31, 2022 −$539.02K
Operating Income Q2 2024 · Dec 31, 2022 −$1.28M